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In the present study the photoreactivity of the fungal carcinogen ochratoxin A (OTA) has been utilised to 
generate authentic samples of reduced glutathione (GSH) and N-acetylcysteine (NAC) conjugates of the 
parent toxin. These conjugates, along with the nontoxic OTα, which is generated through hydrolysis of 
the amide bond of OTA by carboxypeptidase A, were utilised as biomarkers to study the metabolism of 
OTA in the liver and kidney of male and female Dark Agouti rats. Male rats are more susceptible than 
female rats to OTA carcinogenesis with the kidney being the target organ. Our studies show that the 
distribution of OTA in male and female rat kidney is not signiﬁ cantly different. However, the extent of 
OTA metabolism was greater in male than female rats. Much higher levels of OTα were detected in the 
liver compared to the kidney, and formation of OTα is a detoxiﬁ cation pathway for OTA. These ﬁ ndings 
suggest that differences in metabolism between male and female rats could provide an explanation for the 
higher sensitivity of male rats to OTA toxicity.
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N-acetylcysteine
Ochratoxin A (OTA, Figure 1) is a mycotoxin 
produced by several fungi of Aspergillus and 
Penicillium species (1-5). It consists of a chlorophenolic 
group containing a dihydroisocoumarin moiety that 
is amide-linked to phenylalanine. The toxin is a 
common contaminant of cereals and agricultural 
products (2, 3), and the International Agency for 
Research on Cancer (IARC) has classiﬁ ed OTA as a 
possible human carcinogen (group 2B) (6). OTA is 
nephrotoxic and is a potent renal carcinogen in rats 
(7) and in chicks (8). In humans, OTA has been 
associated with nephropathies in the Balkans (9) and 
in North African countries (10).
Because OTA is a possible human carcinogen 
present in food products, tolerable daily intakes (TDIs) 
are proposed by government agencies to manage the 
risk of OTA exposure. The TDI for OTA established 
by the Joint FAO/WHO Expert Committee on Food 
Additives has been set at ~ 14.28 ng kg-1 b.w. per day 
(100 ng kg-1 b.w. per week), based on nephrotoxic 
effects in pigs (11). Health Canada has proposed a 
TDI of 4 ng kg-1 b.w. per day that considers tumour 
formation by OTA (5). These differences in TDI stem 
from a lack of consensus concerning the mechanism 
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of action (MOA) for OTA. However, Hibi et al. (12) 
have recently demonstrated the in vivo mutagenicity 
of OTA in male rat kidney, suggesting involvement of 
a direct genotoxic mechanism in OTA-mediated renal 
carcinogenesis. The more stringent TDI proposed for 
OTA by Health Canada is more in line with carcinogens 
whose MOA involves direct genotoxicity (5).
Direct genotoxicity by OTA may stem from its 
oxidative metabolism into electrophiles that are 
capable of reacting covalently with DNA to generate 
DNA adducts (13, 14). OTA possesses a chlorophenolic 
group, and chlorophenols are well known to undergo 
oxidative dechlorination reactions to afford quinone/
hydroquinone redox couples (15, 16). The hydroquinone 
metabolite (OTHQ, Figure 1) of OTA has been 
detected in the urine (17) and kidneys (18) of rats, and 
in human blood and urine samples (19). Oxidation of 
OTHQ generates the quinone electrophile OTQ that 
reacts with DNA to generate covalent DNA adducts, 
as evidenced using 32P-postlabeling (20). OTA also 
reacts photochemically with 2′-deoxyguanosine (dG) 
to generate a carbon (C)-linked nonchlorinated 
ochratoxin B (OTB)-dG adduct (21) that has recently 
been detected in the kidney of male rats using liquid 
chromatography-mass spectrometry (LC-MS) (22). 
The C5-Cl atom of OTA plays a critical role in OTB-
dG formation, as the nonchlorinated OTB analog lacks 
direct genotoxicity and does not react photochemically 
with dG to generate the OTB-dG adduct (23). 
The C5-Cl atom of OTA also plays a role in its 
metabolism by carboxypeptidase A into the nontoxic 
ochratoxin a (OTα, Figure 1) and phenylalanine. The 
nonchlorinated OTB derivative undergoes hydrolysis 
by carboxypeptidase A at a faster rate than OTA (24, 
25) and this has been invoked as a rationale for the 
lower toxicity of the OTB analog (26). The nontoxic 
OTα has previously been detected as the major OTA 
metabolite in human blood and urine samples (27) and 
may serve as a sensitive biomarker for OTA exposure 
(28). Other biomarkers for OTA exposure would 
include the OTB-dG adduct (22), as OTA is mutagenic 
(12), and OTB-dG formation suggests that a reactive 
metabolite of OTA has reached a toxicologically 
signiﬁ cant target (DNA). However, the presence of 
OTB-dG in treated rat kidney samples is low, 20 to 
70 per 109 nucleotides (22). Furthermore, the adduct 
OTB-dG is unstable and undergoes hydrolysis in the 
presence of acid, which is commonly used for OTA 
extraction from biological and food samples (27, 29). 
These traits (low abundance and poor stability) make 
OTB-dG unsuitable as a general biomarker for OTA 
exposure.
Electrophiles generated from the metabolism of 
OTA also react with reduced glutathione (GSH) to 
produce GSH-conjugates. The OTB-GSH conjugate 
(Figure 1) is the major species formed from the 
photoreaction of OTA with excess GSH (23) and 



















































Figure 1 Chemical structures of OTA and OTA metabolites.
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attachment of GSH to the quinone electrophile OTQ 
affords OTHQ-GSH (Figure 1) that has been 
characterised previously using NMR spectroscopy and 
is generated by treatment of OTA with rat liver 
microsomes in the presence of excess GSH (30). 
Unlike the DNA adduct OTB-dG, OTB-GSH and 
OTHQ-GSH are stable to acid treatment and can be 
extracted from biological samples using methodology 
established for extraction of the parent toxin OTA (27, 
29).
In the present study authentic samples of OTB-
GSH, OTHQ-GSH, and the corresponding
N-acetylcysteine (NAC) conjugates of OTA have been 
used as biomarkers to examine OTA metabolism in 
the liver and kidney of male and female rats. Our goal 
was to use the conjugates to determine sex and organ 
differences in OTA metabolism, given that the male 
rat is particularly susceptible to OTA-mediated 
carcinogenesis, with the kidney being the target organ 
(7). Our studies provide new evidence for OTB-GSH 
and OTHQ-GSH formation in liver and kidney of both 
sexes. Interestingly, clear differences in the extent of 
OTB-GSH versus OTHQ-GSH formation was 
observed in male versus female and liver versus 
kidney, with the male kidney providing preferential 
OTB-GSH formation. These ﬁ ndings may help shed 




OTA (benzene free, CAS# 303-47-9) was purchased 
from Sigma (Saint Quentin Fallavier, France). A 
synthetic sample of OTHQ (30) was available in the 
laboratory at Guelph, Canada, and was used as a 
mixture of diastereomers [3(R, S)], (Figure 1). Stock 
solutions of OTA and OTHQ in aqueous 50 mmol 
L-1 phosphate buffer pH 7.4 were prepared as outlined 
previously (31, 32). Glutathione (GSH) and N-
acetylcysteine (NAC) were purchased from Sigma-
Aldrich (Oakville, ON, Canada). All HPLC solvents 
were of chromatography grade and water used for 
buffers was obtained from a MilliQ ﬁ ltration system 
(18.2 MW).
Synthesis of GSH and NAC Conjugates
Authentic samples of GSH and NAC conjugates 
of OTA were generated from the photoreaction of OTA 
or OTHQ with GSH or NAC. Reaction mixtures (2 mL 
total volume) of 1 mmol L-1 OTA or OTHQ in the 
presence of 15 molar equivalent GSH or NAC were 
irradiated at 350 nm using a Rayonet Chamber 
Reactor, model RPR-200, as outlined for the synthesis 
of OTB-GSH and OTHQ-GSH (23). The photoreaction 
of OTA in the presence of GSH or NAC was used for 
the generation of OTB-GSH or OTB-NAC, while the 
corresponding photoreaction of OTHQ with GSH or 
NAC was used for the preparation of OTHQ-GSH or 
OTHQ-NAC. Puriﬁ cations were performed using an 
Agilent 1200 series HPLC equipped with an 
autosampler, autocollector, diode array detector 
(monitored at 258 nm and 340 nm) and ﬂ uorescence 
detector [excitation (λext) = 340 nm; emission (λem) = 
465 nm]. Separations were carried out using an Agilent 
C18 column (150 mm x 4.6 mm, particle size 5 μm) 
with the following mobile phase: 0.1 % formic acid 
in H2O:0.1 % formic acid in acetonitrile (70:30) to 
(25:75) in 17 min by a linear gradient at a ﬂ ow rate of 
0.75 mL min-1. The GSH- and NAC-conjugate peaks 
were combined and lyophilised to dryness using a 
Labconco FreeZone4.5 freeze-dry system. The authentic 
conjugate samples were checked for purity through 
HPLC analysis (>96 % based on integration of the 
HPLC trace) and were characterised by MS. Mass 
spectra were obtained using an Agilent 1100 LC-MSD 
with a single quadrupole detector with electrospray 
negative ionisation (ESI–). The OTB-NAC conjugate 
was also characterised by nuclear magnetic resonance 
(NMR) spectroscopy on a Bruker Avance 600 MHz 
NMR spectrometer equipped with a HCN pulsed-ﬁ eld 
gradient cryoprobe. Data collection was carried out at 
room temperature in 2H6-dimethyl sulfoxide, DMSO-
d6 (99.9 %) in a 2 mm NMR tube. The 
1H NMR 
spectrum was acquired using 1024 scans and a sweep 
width of 10 ppm. The two-dimensional 1H-1H 
correlation (COSY) spectrum was collected with 2048 
complex points in t2, 512 points in t1, and 64 transients 
per t1 increment. Data were multiplied with optimised 
phase-shifted squared sinebell apodization functions 
with zero ﬁ lling to 1024 points in the t1 dimension. 
Spectra were referenced to the DMSO-d5H peak at 
2.50 ppm and were processed using the Topspin 2.1 
software (Bruker BioSpin Ltd., Milton, Canada).
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Rat tissue samples
Dark Agouti rat lung, liver, and kidney samples 
were available in the laboratory at Toulouse, France 
and were obtained from a rat study performed by CIT 
(International Centre of Toxicology, Evreux) in 
compliance with the Principles of Good Laboratory 
Practice as described in: (i) OECD Principles on Good 
Laboratory Practice (revised in 1997), ENV/MC/
CHEM (98) 17 and (ii) Commission Directive 
1999/11/EC of 8th March 1999 adapting to technical 
progress the Principles of Good Laboratory Practice 
as speciﬁ ed in the Council Directive 87/18/EEC on 
the harmonisation of laws, regulations and 
administrative provisions relating to the application 
of the Principles of Good Laboratory Practice and the 
veriﬁ cation of their applications for tests on chemical 
substances (OJ No. L 77 of 23rd March 1999). The rat 
study was modelled after the protocol described in 
depth in the paper by Castegnaro et al. (27). In the 
current study, 7-week-old Dark Agouti rats were fed 
wheat contaminated with various concentrations of 
OTA over a 28-day period. The rats (25 males and 25 
females) were housed in individual cages (43 cm x 
21.5 cm x 20 cm) and kept in environmentally 
controlled conditions (ventilation, 22°C, 12 h dark/
light cycles). The wheat provided by the French miller 
(Paulic Minotiers) was of a common variety used for 
making bread. All rats had free access to non-
contaminated wheat over a 7-day acclimation period. 
This was followed by exposure of the rats to OTA-
contaminated wheat. One batch of 8 kg was coded as 
control. Four batches, 8 kg each, were artiﬁ cially 
contaminated with OTA, respectively at: 2.5 μg kg-1, 
7 μg kg-1, 40 μg kg-1, and 100 μg kg-1. To uniformly 
incorporate OTA into the wheat, OTA was dissolved 
in ethanol and introduced into the wheat (in the 
presence of 1 % water) as a ﬁ ne spray over a 15-min 
period. Each batch of 8 kg wheat was distributed into 
53 plastic bags, each containing 150 g of wheat. The 
plastic bags were stored at -20 °C in closed plastic 
containers and were allowed to thaw at room 
temperature 1 day prior to use. The OTA content of 
the wheat samples was conﬁ rmed using HPLC with 
ﬂ uorescence detection (29). On completion of the 
treatment period, the rats were euthanised and the 
organs were weighed and frozen at – 80 °C until 
use.
OTA and metabolite extraction 
OTA and its metabolites were extracted from the 
organ tissue samples using a procedure similar to the 
one outlined by Molinié et al. (29) for the extraction 
of OTA from cereals and modified by Pfohl-
Leszkowicz et al. (33). Tissue samples (1 g) were 
homogenised in the presence of 20 mL 0.1 mol 
L-1 MgCl2 and 0.05 mol L
-1 HCl (pH 1.5). The aqueous 
acidic solution was then extracted three times with 
CHCl3 (20 mL, 10 mL, 10 mL). Following each CHCl3 
treatment, the samples were centrifuged (10 min, 
~3,000 x g, 4 °C) in order to separate the CHCl3 
component from the acidic aqueous phase. The 
combined CHCl3 extracts were then treated with 
40 mL sodium bicarbonate and the solution was 
shaken for ~ 10 min. The bicarbonate solution was 
collected and acidiﬁ ed to pH 1.5 with HCl and then 
extracted three times (3 x 20 mL) with CHCl3. The 
combined CHCl3 extracts were dried under vacuum 
and the resulting residue was dissolved in 1 mL 
methanol, ﬁ ltered, and concentrated under nitrogen to 
a ﬁ nal volume of 200 μL.
OTA and OTA metabolite analysis
Reverse-phase HPLC analysis of OTA and its 
metabolites were carried out using a Gilson 811B 
dynamic HPLC pump. OTA was analysed using a 
Nucleosil 100-3 C18 column (150 mm x 4.6 mm, 
particle size 3 mm) under isocratic elution (methanol, 
600 mL; acetonitrile, 600 mL; water, 800 mL; sodium 
acetate, 0.68 g; glacial acetic acid, 28 mL) with 
detection performed with a programmable ﬂ uorimeter 
GTI spectrovision (λext=340 nm; λem=465 nm). The 
limit of detection (LOD) was 0.05 ng g-1; the limit of 
quantiﬁ cation (LOQ) was 0.2 ng g-1 (34). The OTA 
metabolites were separated using a Prontosil C18 
column (250 mm x 4 mm, particle size 3 μm) with 
solvent A: methanol:acetonitrile:6.5 mmol L-1 
ammonium formate (200:200:600) adjusted to pH 3 
with formic acid; and solvent B: methanol:
acetonitrile:6.5 mmol L-1 ammonium formate 
(350:350:300) adjusted to pH 3 with formic acid, using 
gradient elution, as outlined previously (34, 35). 
Detection was also performed using the ﬂ uorimeter 
GTI spectrovision (λext=340 nm; λem=465 nm) that 
permitted a LOD of ~ 0.05 ng g-1 for OTA.
RESULTS
Generation of GSH and NAC conjugates
The photoreaction of OTA or OTHQ in the 
presence of 15 molar equivalent GSH or NAC was 
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utilised to generate the GSH- and NAC-conjugates of 
OTA. As outlined previously (23), photoirradiation 
(15 min) of OTA (1 mmol L-1) at 350 nm in the 
presence of excess GSH generates OTB-GSH (Figure 
1) as the major product. The conjugate has a phenolic 
absorption at lmax = 331 nm and a parent ion at m/z 
673. In the negative ESI spectrum a major fragment 
ion is observed at m/z 400, which is 32 mass units 
heavier than OTB (m/z 368) and stems from
b-elimination of the attached benzoquinol-SH (23). 
The photoreaction also generates OTHQ-GSH (Figure 
1) as a minor product (23) that forms by nucleophilic 
attachment of GSH to the quinone electrophile OTQ 
(30). This conjugate is the sole species formed from 
the photoreaction of OTHQ (1 mmol L-1) with excess 
GSH. It has been fully characterised previously using 
NMR spectroscopy and possesses a phenolic 
absorption at lmax = 352 nm and a parent ion at m/z 689 
with a prominent fragment ion at m/z 416 from
b-elimination of benzoquinol-SH (23, 30).
Figure 2 shows the ESI– spectra of the corresponding 
NAC-conjugates of OTA (OTB-NAC) and OTHQ 
(OTHQ-NAC). The OTB-NAC conjugate had a 
phenolic absorption at 331 nm and a parent ion at
m/z 529 with a major fragment at m/z 400 (Figure 2A), 
as noted for fragmentation of OTB-GSH. The phenolic 
absorption of OTHQ-NAC occurred at 360 nm and 
the conjugate had a parent ion at m/z 545 with a major 
fragment at m/z 416 (Figure 2B). Spectral data for 
OTA, OTHQ and the corresponding GSH- and NAC-
conjugates are given in Table 1.
The OTB-NAC conjugate was also characterised 
by NMR spectroscopy. Figure 3 shows the two-
dimensional 1H-1H correlation (COSY) spectrum of 
the conjugate recorded in DMSO-d6 at room 
temperature. The 1H chemical shifts of the conjugate 
are given in Table 2. The Table also includes 1H 
chemical shift data for OTHQ, which was also 
recorded in DMSO-d6 (16), and OTA, which was 
recorded in CDCl3 by Dais et al. (36). The NMR data 
together with the MS data provided an unambiguous 
assignment of the OTB-NAC structure, as 1H signals 
for the attached NAC moiety could be determined and 
H-6 of the OTB component was observed at ~ 8 ppm, 
as expected from the 1H NMR data for OTHQ (16) 
and OTA (36).
Table 1 Spectral data for photoreactions of OTA and OTHQ with GSH and NACa
species RTc λmaxd parent ion m/z fragment ions m/z
OTAb 13.3 333 402 358, 314
OTHQb 10.9, 11.0 350 384 340, 296
OTB-GSHb 6.8 331 673 672, 544, 400
OTHQ-GSHb 6.2 352 689 688, 560, 416
OTB-NAC 9.5 331 529 400
OTHQ-NAC 8.0, 8.2 360 545 416
a Photoreactions of ochratoxins (1 mmol L-1) in the presence of 15 molar equivalent GSH or NAC were carried out in 50 mmol 
L-1 phosphate buffer pH 7.4 for 15 min with irradiation at 350 nm using a Rayonet Chamber Reactor, Model RPR-200.
b Data taken from reference 23.
c Retention time in minutes using an Agilent C18 (150 mm x 4.6 mm, 5 mm particle size) column with a ﬂ ow rate of 0.75 mL
min-1 using the following mobile phase: 0.1 % formic acid in H2O:0.1 % formic acid in ACN (70:30) to (25:75) in 17 min by a 
linear gradient.
d Phenolic ring absorbance in nm.
Figure 2  Negative ionisation electrospray mass spectra of (A) 
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Rat studies
From the rat study it was noted that the weight gain 
of both male and female Dark Agouti rats was 
unaffected by the level of OTA ingestion (2.5 μg kg-1, 
40 μg kg-1, and 100 μg kg-1) following the 28-day 
period. Figure 4 shows the corresponding changes in 
liver and kidney weight for males and females. A 
signiﬁ cant decrease (p<0.01, Student t-test) in male 
(A) and female (C) liver weight was observed for all 
rats receiving OTA, regardless of concentration, 
compared to the control (C in the x-axis). This was 
not the case for the kidney weight (B, D). For both 
males (B) and females (D), the highest dose (100 μg 
kg-1) of OTA did not signiﬁ cantly affect the kidney 
weight compared to the control, even though using 
Wilcoxon rank test a signiﬁ cant decrease was observed 
with lower doses.
Figure 3  1H-1H COSY spectrum of OTB-NAC recorded at 
600 MHz in DMSO-d6.
Table 2 Proton NMR data for OTB-NAC, OTHQ and OTA.
proton δ 1H OTB-NACa δ 1H OTHQb δ1H OTAc
H-3 4.39 4.29 4.69
H-4a 3.35 3.12 3.22
H-4b 2.55 2.66 2.79
H-6 8.06 7.72 8.36
H-13 4.43 4.29 4.96
H-14a 3.12 3.12 3.30
H-14b 3.08 3.12 3.15
H-16-20 (phenyl) 7.19 to 7.23 7.29 7.13 to 7.30
H-21 (CH3) 1.34 1.43 1.53
H-23a 3.06 _ _
H-23b 2.81 _ _
H-24 3.91 _ _
H-25 (NH) 7.53 _ _
H-27 (CH3) 1.75 _ _
a 1H NMR chemical shifts in ppm recorded at 600 MHz in DMSO-d6.
b Chemical shift data taken from reference 16, recorded at 300 MHz in DMSO-d6.
c Chemical shift data taken from reference 36, recorded at 400 MHz in CDCl3.
Figure 4  Change in liver (A, C) and kidney (B, D) weight of 
male (A, B) and female (C, D) Dark Agouti rats 
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Figure 5 shows the distribution of OTA in the lung, 
liver, and kidney of male (A) and female (B) Dark 
Agouti rats following varying levels of OTA exposure 
for the 28-day period. The levels of OTA (ng g-1) 
presented in Figure 5 were obtained following OTA 
extraction from the tissues and performing HPLC 
analysis with fluorescence detection (excitation 
340 nm, emission 465 nm), using an authentic sample 
of OTA for comparison for an LOD of 0.05 ng g-1 and 
an LOQ of 0.2 ng g-1. The relative levels of OTA in 
the tissues of both sexes were similar to the highest 
levels being found in the lung and liver. The OTA 
amounts in different tissues increased with OTA 
dose.
samples, while the corresponding HPLC chromatograms 
from the analysis of the male (A) and female (B) 
kidney samples are shown in Figure 7. In both tissue 
samples peaks corresponding to the NAC-conjugates 
were not observed. However, peaks that co-migrated 
with OTα and the GSH-conjugates were found. 
Compared to the peak for OTA, levels of metabolite 
formation were greater for males (A) than females (B) 
in both liver (Figure 6) and kidney (Figure 7). The 
most striking difference between kidney and liver in 
both sexes was the high degree of OTB-GSH formation 
in the kidney relative to OTα and OTHQ-GSH. The 
liver of both sexes generated higher levels of OTHQ-
GSH, and relatively high levels of OTα were also 
detected in male rats (Figure 6A).
Figure 5  Distribution of OTA in tissues of male (A) and female 
(B) Dark Agouti rats following varying levels of OTA 
exposure for 28 days.
For rats receiving the highest dose (100 μg kg-1) 
of OTA, tissue samples were also analysed for 
metabolite formation using authentic samples of OTa, 
OTB-GSH, OTHQ-GSH, OTB-NAC, and OTHQ-
NAC for comparison. For these studies, OTA and its 
metabolites extracted from four liver and four kidney 
samples from each sex were combined for HPLC 
analysis with fluorescence detection (excitation 
340 nm, emission 465 nm) after gradient separation. 
Figure 6 shows a representative HPLC chromatogram 
depicting the relative levels of OTA, OTα, OTB-GSH, 
and OTHQ-GSH from male (A) and female (B) liver 
Figure 6  HPLC chromatograms with ﬂ uorescence detection 
(excitation 340 nm, emission, 465 nm) showing 
relative levels of OTA, OTα, OTB-GSH and OTHQ-
GSH from male (A) and female (B) livers (4 from 
each sex) following treatment with 100 μg kg-1 OTA 
for 28 days. 
DISCUSSION
The results of our studies highlight the potential 
utility of GSH- and NAC-conjugates of OTA and 
OTHQ as biomarkers for OTA exposure. The 
photoreaction of OTA in the presence of excess GSH 
(23) or NAC can be used to readily generate authentic 
samples of OTB-GSH, OTHQ-GSH (Figure 1), or 
OTB-NAC and OTHQ-NAC (Figure 2). The OTHQ-
GSH conjugate stems from the attachment of GSH to 
the quinone (OTQ) electrophile, which is produced 
by cytochrome P450 metabolism of OTA (16, 20). The 
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photochemically from displacement of the C5-Cl atom 
of OTA by the sulphur atom of GSH or NAC. The 
electrophilic intermediate in this reaction also reacts 
with dG to yield the OTB-dG adduct (21), which has 
been detected by LC-MS in the kidney of male rats 
fed a carcinogenic dose of OTA (22). Thus, OTB-GSH 
and OTHQ-GSH, along with the corresponding NAC-
conjugates, were considered as appropriate biomarkers 
for OTA exposure. The conjugates stem from the same 
electrophiles that are deemed important for OTA-
mediated DNA adduction (14), which is now expected 
to play a key role in the mutagenicity and carcinogenicity 
of OTA (12). However, unlike the DNA adducts 
generated by OTA, the GSH- and NAC-conjugates of 
OTA are stable to acid and can be extracted from 
biological tissues using strategies developed for the 
parent toxin (27, 29, 37). This suggested that the 
conjugates would be easier to detect than the 
corresponding DNA adducts and would still serve as 
an indication that the biological target (DNA) had been 
exposed to OTA-mediated electrophiles.
To test the potential for conjugate formation by 
OTA, Dark Agouti rat liver and kidney samples were 
analysed for levels of OTA, OTα, OTB-GSH, OTHQ-
GSH, OTB-NAC, and OTHQ-NAC, using HPLC with 
ﬂ uorescence detection (34, 35). The rat organ samples 
were available from a study in which 7-week-old Dark 
Agouti male and female rats were fed various 
concentrations of OTA in wheat for a period of 28 
days; similar to the protocol previously reported (27). 
Given that male rats are more susceptible than females 
to OTA-mediated carcinogenesis (7, 38), it was 
anticipated that the conjugate formation analysis 
would provide new insights into sex and organ 
differences in OTA-mediated metabolism, which 
might help explain the susceptibility of male rat kidney 
to OTA (39, 40).
Initially, the impact of OTA on liver and kidney 
weight (Figure 4) and the distribution of OTA in the 
lung, liver, and kidney of male and female rats (Figure 
5) were analysed. The distribution study (Figure 5) 
showed no signiﬁ cant difference between males and 
females regarding OTA concentrations, which is in 
agreement with a recent study carried out by Vettorazzi 
et al. (41) on the distribution of OTA in male and 
female F344 rats. These studies suggest that other 
factors, such as differences in metabolism (40, 42), 
could explain the higher sensitivity of male rats to 
OTA carcinogenicity.
The HPLC data presented in Figures 6 and 7 
demonstrate that differences in OTA metabolism 
between male and female rats and between the liver 
(Figure 6) and the kidney (Figure 7) do exist. In both 
liver and kidney the extent of OTA metabolism was 
greater in male than female rats. In the kidney, both 
sexes generate OTB-GSH as the principle metabolite. 
This was not the case in the liver where male rats 
generated appreciable quantities of OTα and OTHQ-
GSH in addition to OTB-GSH (Figure 6A). The female 
rats also generated low levels of all three metabolites 
(Figure 6B). These results provide insight into the 
susceptibility of male rat kidney to OTA carcinogenesis. 
First, male rats generate higher levels of GSH-
conjugates than female rats, suggesting a greater level 
of OTA bioactivation, which is required for DNA 
adduction (13, 14) and probably in vivo mutagenicity 
(12). Second, much higher levels of OTa are detected 
in the liver (Figure 6A) compared to the kidney (Figure 
7A) and formation of OTα is a detoxiﬁ cation pathway 
for OTA (24-26), suggesting greater sensitivity of the 
kidney to OTA. At present, the GSH-conjugates of 
OTA in rat liver and kidney were characterised by 
HPLC with ﬂ uorescence detection using authentic 
samples for comparison. Future studies will focus on 
the use of LC-MS/MS strategies to unambiguously 
conﬁ rm the presence of the GSH-conjugates in the rat 
tissue samples. The GSH- and NAC-conjugates 
reported in this work will also be used as standards 
for the analysis of urine samples taken from animals 
and humans exposed to OTA.
Figure 7  HPLC chromatograms with ﬂ uorescence detection 
(excitation 340 nm, emission, 465 nm) showing 
relative levels of OTA, OTα, OTB-GSH and OTHQ-
GSH from male (A) and female (B) kidneys (4 from 
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CONCLUSION
We demonstrated that exposure of male and female 
rats to OTA results in the production of GSH-
conjugates that have been detected using HPLC with 
ﬂ uorescence detection. These results suggest that OTA 
undergoes metabolism in rat liver and kidney to 
generate electrophiles that react covalently with GSH. 
These data add additional support to the hypothesis 
that differences in OTA metabolism between male and 
female rats provide a rationale for the sensitivity of 
male rat kidney to OTA carcinogenesis.
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Sažetak
GLUTATIONSKI KONJUGATI OKRATOKSINA A KAO BIOMARKERI IZLOŽENOSTI
U ovom je ispitivanju korištena fotoreaktivnost kancerogenog mikotoksina okratoksina A (OTA) kako bi 
se stvorili izvorni uzorci reduciranih glutationskih (GSH) i N-acetilcisteinskih (NAC) konjugata osnovnog 
toksina. Ovi konjugati, uz netoksični OTα, koji se stvara hidrolizom amidne veze OTA putem 
karboksipeptidaze A, upotrijebljeni su kao biomarkeri za ispitivanje metabolizma OTA u jetri i bubregu 
ženki i mužjaka štakora soja Dark Agouti. Mužjaci su se pokazali podložnijima stvaranju bubrežnih tumora 
uzrokovanih OTA toksinom od ženki. Utvrdili smo da se raspodjela OTA u bubrezima ženki i mužjaka 
značajno ne razlikuje. Međutim mužjaci su imali intenzivniji metabolizam OTA nego ženke. U jetri su 
utvrđene mnogo više razine OTα u usporedbi s bubregom, a rezultati upućuju na to da je stvaranje OTα 
detoksiﬁ kacijski put za OTA. Zaključujemo da bi se veća osjetljivost mužjaka štakora na toksičnost OTA 
mogla pripisati spolno uvjetovanim razlikama u njegovu metabolizmu.
KLJUČNE RIJEČI: bioaktivacija, glutation, kancerogenost, metabolizam, mutagenost, N-acetilcistein, 
okratoksin A, stvaranje adukata u molekuli DNA
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